Source link : https://www.newshealth.biz/health-news/fda-reviewers-voice-concerns-over-novel-uti-treatment/
Ahead of an Antimicrobial Drugs Advisory Committee meeting on Monday, FDA reviewers voiced ongoing concerns about the benefits versus risks of a novel oral antibiotic for the treatment of uncomplicated urinary tract infections (uUTIs), including its potential for inappropriate use. The drug in question — sulopenem etzadroxil/probenecid (sulopenem) — is a penem antibiotic with in […]
Author : News Health
Publish date : 2024-09-06 20:38:41
Copyright for syndicated content belongs to the linked Source.